BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND ZFHX3, ATBT, 463, ENSG00000140836, Q15911 AND Treatment
26 results:

  • 1. Clinical activity and safety of sintilimab, bevacizumab, and TMZ in patients with recurrent glioblastoma.
    Lu Y; Liao L; Du K; Mo J; Zou X; Liang J; Chen J; Tang W; Su L; Wu J; Zhang J; Tan Y
    BMC Cancer; 2024 Jan; 24(1):133. PubMed ID: 38273249
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. All-Cause and Cause-Specific Mortality Among Low-Risk Differentiated Thyroid cancer Survivors in the United States.
    Tran TV; Schonfeld SJ; Pasqual E; Haymart MR; Morton LM; Kitahara CM
    Thyroid; 2024 Feb; 34(2):215-224. PubMed ID: 38149602
    [No Abstract]    [Full Text] [Related]  

  • 3. Plasma Proteomics to Identify Drug Targets for Ischemic Heart Disease.
    Mazidi M; Wright N; Yao P; Kartsonaki C; Millwood IY; Fry H; Said S; Pozarickij A; Pei P; Chen Y; Avery D; Du H; Schmidt DV; Yang L; Lv J; Yu C; Chen J; Hill M; Holmes MV; Howson JMM; Peto R; Collins R; Bennett DA; Walters RG; Li L; Clarke R; Chen Z;
    J Am Coll Cardiol; 2023 Nov; 82(20):1906-1920. PubMed ID: 37940228
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Epigenomic and transcriptomic landscaping unraveled candidate repositioned therapeutics for non-functioning pituitary neuroendocrine tumors.
    Aydin B; Beklen H; Arga KY; Bayrakli F; Turanli B
    J Endocrinol Invest; 2023 Apr; 46(4):727-747. PubMed ID: 36306107
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Age and Gender Specific Lung cancer Incidence and Mortality in Hungary: Trends from 2011 Through 2016.
    Tamási L; Horváth K; Kiss Z; Bogos K; Ostoros G; Müller V; Urbán L; Bittner N; Sárosi V; Vastag A; Polányi Z; Nagy-Erdei Z; Daniel A; Nagy B; Rokszin G; Abonyi-Tóth Z; Moldvay J; Vokó Z; Gálffy G
    Pathol Oncol Res; 2021; 27():598862. PubMed ID: 34257553
    [No Abstract]    [Full Text] [Related]  

  • 6. Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study.
    Weill A; Nguyen P; Labidi M; Cadier B; Passeri T; Duranteau L; Bernat AL; Yoldjian I; Fontanel S; Froelich S; Coste J
    BMJ; 2021 Feb; 372():n37. PubMed ID: 33536184
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Postoperative Complications of Endoscopic Versus Microscopic Transsphenoidal Pituitary Surgery: A Meta-Analysis.
    Fang J; Xie S; Li N; Jiang Z
    J Coll Physicians Surg Pak; 2018 Jul; 28(7):554-559. PubMed ID: 29950263
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Predictors of 30-day mortality and the risk of recurrent systemic thromboembolism in cancer patients suffering acute ischemic stroke.
    Nam KW; Kim CK; Kim TJ; An SJ; Oh K; Mo H; Kang MK; Han MK; Demchuk AM; Ko SB; Yoon BW
    PLoS One; 2017; 12(3):e0172793. PubMed ID: 28282388
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Development of symptomatic brain metastases after chemoradiotherapy for stage III non-small cell lung cancer: Does the type of chemotherapy regimen matter?
    Hendriks LEL; Brouns -JWM; Amini M; Uyterlinde W; Wijsman R; Bussink J; Biesma B; Oei SB; Stigt JA; Bootsma GP; Belderbos JSA; De Ruysscher DKM; Van den Heuvel MM; Dingemans AC
    Lung Cancer; 2016 Nov; 101():68-75. PubMed ID: 27794410
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Evaluation of pseudoprogression rates and tumor progression patterns in a phase III trial of bevacizumab plus radiotherapy/temozolomide for newly diagnosed glioblastoma.
    Wick W; Chinot OL; Bendszus M; Mason W; Henriksson R; Saran F; Nishikawa R; Revil C; Kerloeguen Y; Cloughesy T
    Neuro Oncol; 2016 Oct; 18(10):1434-41. PubMed ID: 27515827
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Aspirin for Stroke Prevention in Elderly Patients With Vascular Risk Factors: Japanese Primary Prevention Project.
    Uchiyama S; Ishizuka N; Shimada K; Teramoto T; Yamazaki T; Oikawa S; Sugawara M; Ando K; Murata M; Yokoyama K; Minematsu K; Matsumoto M; Ikeda Y;
    Stroke; 2016 Jun; 47(6):1605-11. PubMed ID: 27165949
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma.
    Chinot OL; Wick W; Mason W; Henriksson R; Saran F; Nishikawa R; Carpentier AF; Hoang-Xuan K; Kavan P; Cernea D; Brandes AA; Hilton M; Abrey L; Cloughesy T
    N Engl J Med; 2014 Feb; 370(8):709-22. PubMed ID: 24552318
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. First experiences in treatment of low-grade glioma grade I and II with proton therapy.
    Hauswald H; Rieken S; Ecker S; Kessel KA; Herfarth K; Debus J; Combs SE
    Radiat Oncol; 2012 Nov; 7():189. PubMed ID: 23140402
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Physician self-reported treatment of brain metastases according to patients' clinical and demographic factors and physician practice setting.
    Kress MA; Ramakrishna N; Makgoeng SB; Unger KR; Potosky AL
    Radiat Oncol; 2012 Nov; 7():188. PubMed ID: 23136987
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Age-specific trends of survival in metastatic breast cancer: 26 years longitudinal data from a population-based cancer registry in Stockholm, Sweden.
    Foukakis T; Fornander T; Lekberg T; Hellborg H; Adolfsson J; Bergh J
    Breast Cancer Res Treat; 2011 Nov; 130(2):553-60. PubMed ID: 21617918
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Cabergoline therapy for prolactinomas: is valvular heart disease a real safety concern?
    Vallette S; Serri K; Serri O
    Expert Rev Cardiovasc Ther; 2010 Jan; 8(1):49-54. PubMed ID: 20014934
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Cabergoline in hyperprolactinemia and valvular heart disease].
    Vargas ML; Cervantes CE; Hernando CA; Da Costa CV
    Endocrinol Nutr; 2009 Oct; 56(8):412-7. PubMed ID: 19959151
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Adrenocorticotrophic hormone (ACTH) responsiveness to ghrelin increases after 6 months of ketoconazole use in patients with Cushing's disease: comparison with GH-releasing peptide-6 (GHRP-6).
    Correa-Silva SR; Nascif SO; Molica P; Sá LB; Vieira JG; Lengyel AM
    Clin Endocrinol (Oxf); 2010 Jan; 72(1):70-5. PubMed ID: 19453623
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Cerebellar mutism.
    Turgut M
    J Neurosurg Pediatr; 2008 Mar; 1(3):262. PubMed ID: 18352776
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: a prospective study by the Children's Oncology Group.
    Robertson PL; Muraszko KM; Holmes EJ; Sposto R; Packer RJ; Gajjar A; Dias MS; Allen JC;
    J Neurosurg; 2006 Dec; 105(6 Suppl):444-51. PubMed ID: 17184075
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.